Synapse - Phillip Wong

Phillip Wong

Research Focus

Research Facilities; Associate Lab Member

https://orcid.org/0000-0002-6360-849X

4683

Recent additions – View all

Characterizing the immune effects of enfortumab vedotin (EV) on peripheral blood mononuclear cells (PBMCs) in metastatic urothelial cancer patients (mUC)
Meeting Abstract

Gupta, A.; Sevilla, C.; Pihlstrom, N. L.; Liang, S.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Wong, P.; Ahmed, F.; Funt, S. A.; more...
Journal of Clinical Oncology (2025)

Fulltext@MSK | Save
Combining a WT1 vaccine (Galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1–expressing diffuse pleural mesothelioma: A phase 1 study
Journal Article

Agrawal, P.; Offin, M.; Lai, V.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
JTO Clinical and Research Reports (2025)

Fulltext@MSK | Save
Peripheral blood (PB) T cell phenotype and tumor microenvironment (TME) subtype are independently associated with immune checkpoint blockade (ICB) outcomes in sarcomas
Meeting Abstract

Rosenbaum, E.; Ehrich, F.; Bradic, M.; Kelly, C. M.; Movva, S.; Chan, J.; Chi, P.; Banks, L.; Dickson, M.; Keohan, M. L.; more...
Annals of Oncology (2024)

Fulltext@MSK | Save

Co-authors at MSK

Types of Work

Publications